Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

被引:1012
作者
Gauglitz, Gerd G. [2 ,3 ]
Korting, Hans C. [2 ]
Pavicic, Tatiana [2 ]
Ruzicka, Thomas [2 ]
Jeschke, Marc G. [1 ,3 ,4 ,5 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada
[2] Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergol, Munich, Germany
[3] Univ Texas Med Branch, Shriners Hosp Children, Dept Surg, Galveston, TX USA
[4] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON M4N 3M5, Canada
[5] Univ Toronto, Dept Surg, Div Plast Surg, Toronto, ON, Canada
关键词
GROWTH-FACTOR-BETA; PULSED-DYE-LASER; IMIQUIMOD 5-PERCENT CREAM; MATRIX-METALLOPROTEINASE; ONION EXTRACT; DOUBLE-BLIND; IN-VITRO; COLLAGENASE PRODUCTION; FIBROBLAST COLLAGEN; MOLECULAR-BASIS;
D O I
10.2119/molmed.2009.00153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Excessive scars form as a result of aberrations of physiologic wound healing and may arise following any insult to the deep dermis. By causing pain, pruritus and contractures, excessive scarring significantly affects the patient's quality of life, both physically and psychologically. Multiple studies on hypertrophic scar and keloid formation have been conducted for decades and have led to a plethora of therapeutic strategies to prevent or attenuate excessive scar formation. However, most therapeutic approaches remain clinically unsatisfactory, most likely owing to poor understanding of the complex mechanisms underlying the processes of scarring and wound contraction. In this review we summarize the current understanding of the pathophysiology underlying keloid and hypertrophic scar formation and discuss established treatments and novel therapeutic strategies. (c) 2011 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: hftp://www.molmed.org dol: 10.2119/molmed.2009.00153
引用
收藏
页码:113 / 125
页数:13
相关论文
共 141 条
[71]   IN SEARCH OF THE OPTIMAL TREATMENT OF KELOIDS - REPORT OF A SERIES AND A REVIEW OF THE LITERATURE [J].
LAWRENCE, WT .
ANNALS OF PLASTIC SURGERY, 1991, 27 (02) :164-178
[72]  
Lee TY, 1999, ANN PLAS SURG, V43, P179
[73]   Treatment of keloids and hypertrophic scars - A meta-analysis and review of the literature [J].
Leventhal, Douglas ;
Furr, Maxwell ;
Reiter, David .
ARCHIVES OF FACIAL PLASTIC SURGERY, 2006, 8 (06) :362-368
[74]   HYPERTROPHIC SCAR - A GENETIC HYPOTHESIS [J].
LEWIS, WHP ;
SUN, KKY .
BURNS, 1990, 16 (03) :176-178
[75]   Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro [J].
Lim, IJ ;
Phan, TT ;
Song, C ;
Tan, WTL ;
Longaker, MT .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 107 (03) :797-808
[76]   The temporal effects of anti-TGF-β1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation [J].
Lu, L ;
Saulis, AS ;
Liu, WR ;
Roy, NK ;
Chao, JD ;
Ledbetter, S ;
Mustoe, TA .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (03) :391-397
[77]   Pressure garments for use in the treatment of hypertrophic scars - a review of the problems associated with their use [J].
Macintyre, L ;
Baird, M .
BURNS, 2006, 32 (01) :10-15
[78]   HISTOGENESIS OF EXPERIMENTALLY PRODUCED KELOIDS [J].
MANCINI, RE ;
QUAIFE, JV .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1962, 38 (03) :143-181
[79]   Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11 [J].
Marneros, AG ;
Norris, JEC ;
Watanabe, S ;
Reichenberger, E ;
Olsen, BR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (05) :1126-1132
[80]   CYTOKINE REGULATION OF METALLOPROTEINASE GENE-EXPRESSION [J].
MAUVIEL, A .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, 53 (04) :288-295